Last mentioned: Mar 16, 2026
ARK Invest CEO Cathie Wood has increased her position in Tempus AI with a $2 million purchase, signaling continued conviction in AI-driven healthcare despite a 15% year-to-date decline. This move comes as Wood's flagship ARKK fund faces renewed pressure, trailing the S&P 500 significantly over a five-year horizon.
ARK Invest CEO Cathie Wood has increased her stake in Tempus AI with a $2 million purchase, signaling continued conviction in high-growth technology despite a 15% year-to-date decline for the stock. This move comes as her flagship Ark Innovation ETF struggles to keep pace with the broader market, currently trailing the S&P 500 as Wood maintains her stance that the AI sector is far from a bubble.
Cathie Wood's ARK Investment Management has purchased $2 million worth of Tempus AI shares, reinforcing its position in the precision medicine firm despite a 15% year-to-date decline. The move underscores Wood's commitment to 'coiled spring' AI and biotech assets, even as her flagship funds face significant performance headwinds compared to the broader market.